BOSULIF (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the BOSULIF drug offered from Pfizer Laboratories Div Pfizer Inc. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
| NON-PROPRIETARY NAME: | Bosutinib monohydrate |
| SUBSTANCE NAME: | BOSUTINIB MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-09-04 |
| END MARKETING DATE: | 0000-00-00 |
BOSULIF HUMAN PRESCRIPTION DRUG Details:
| Item Description | BOSULIF from Pfizer Laboratories Div Pfizer Inc |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2012-09-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0069-0135_173150a0-0bfc-4aef-8ada-bcc3e64fa07f |
| PRODUCT NDC: | 0069-0135 |
| APPLICATION NUMBER: | NDA203341 |
Other BOSUTINIB MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
